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The evaluation of a 2D diode array in "magic phantom" for use in high dose
rate brachytherapy pretreatment quality assurance
Abstract
Purpose: High dose rate (HDR) brachytherapy is a treatment method that is used increasingly worldwide.
The development of a sound quality assurance program for the verification of treatment deliveries can be
challenging due to the high source activity utilized and the need for precise measurements of dwell positions
and times. This paper describes the application of a novel phantom, based on a 2D 11 x 11 diode array
detection system, named "magic phantom" (MPh), to accurately measure plan dwell positions and times,
compare them directly to the treatment plan, determine errors in treatment delivery, and calculate absorbed
dose. Methods: The magic phantom system was CT scanned and a 20 catheter plan was generated to simulate
a nonspecific treatment scenario. This plan was delivered to the MPh and, using a custom developed software
suite, the dwell positions and times were measured and compared to the plan. The original plan was also
modified, with changes not disclosed to the primary authors, and measured again using the device and
software to determine the modifications. A new metric, the "position-time gamma index," was developed to
quantify the quality of a treatment delivery when compared to the treatment plan. The MPh was evaluated to
determine the minimum measurable dwell time and step size. The incorporation of the TG-43U1 formalism
directly into the software allows for dose calculations to be made based on the measured plan. The estimated
dose distributions calculated by the software were compared to the treatment plan and to calibrated EBT3
film, using the 2D gamma analysis method. Results: For the original plan, the magic phantom system was
capable of measuring all dwell points and dwell times and the majority were found to be within 0.93 mm and
0.25 s, respectively, from the plan. By measuring the altered plan and comparing it to the unmodified
treatment plan, the use of the position-time gamma index showed that all modifications made could be readily
detected. The MPh was able to measure dwell times down to 0.067 ± 0.001 s and planned dwell positions
separated by 1 mm. The dose calculation carried out by the MPh software was found to be in agreement with
values calculated by the treatment planning system within 0.75%. Using the 2D gamma index, the dose map of
the MPh plane and measured EBT3 were found to have a pass rate of over 95% when compared to the original
plan. Conclusions: The application of this magic phantom quality assurance system to HDR brachytherapy
has demonstrated promising ability to perform the verification of treatment plans, based upon the measured
dwell positions and times. The introduction of the quantitative position-time gamma index allows for direct
comparison of measured parameters against the plan and could be used prior to patient treatment to ensure
accurate delivery.
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Purpose: High dose rate (HDR) brachytherapy is a treatment method that is used increasingly 
worldwide. The development of a sound quality assurance (QA) program for the verification of 
treatment deliveries can be challenging due to the high source activity utilized and the need for 
precise measurements of dwell positions and times. This paper describes the application of a novel 
phantom, based on a two dimensional 11x11 diode array detection system, named “magic phantom”, 
to accurately measure plan dwell positions and times, compare them directly to the treatment plan, 
determine errors in treatment delivery and calculate absorbed dose. 
Methods: The “magic phantom” (MPh) system was CT scanned and a 20 catheter plan was generated 
to simulate a nonspecific treatment scenario. This plan was delivered to the MPh and, using a custom 
developed software suite, the dwell positions and times were measured and compared to the plan. The 
original plan was also modified, with changes not disclosed to the primary authors, and measured 
again using the device and software to determine the modifications. A new metric, the “position-time 
gamma index”, was developed to quantify the quality of a treatment delivery when compared to the 
treatment plan. The MPh was evaluated to determine the minimum measurable dwell time and step 
size. The incorporation of the TG-43U1 formalism directly into the software allows for dose 
calculations to be made based on the measured plan. The estimated dose distributions calculated by 
 
 
the software were compared to the treatment plan and to calibrated EBT3 film, using the 2D gamma 
analysis method. 
Results: For the original plan, the “magic phantom” system was capable of measuring all dwell points 
and dwell times and the majority were found to be within 0.93 mm and 0.25 s, respectively, from the 
plan. By measuring the altered plan and comparing it to the unmodified treatment plan, the use of the 
position-time gamma index showed that all modifications made could be readily detected. The MPh 
was able to measure dwell times down to 0.067 ± 0.001 s and planned dwell positions separated by 1 
mm. The dose calculation carried out by the MPh software was found to be in agreement with values 
calculated by the treatment planning system within 0.75%. Using the 2D gamma index, the dose map 
of the MPh plane and measured EBT3 were found to have a pass rate of over 95% when compared to 
the original plan. 
Conclusions: Our application of the “magic phantom” quality assurance system to HDR 
brachytherapy has demonstrated promising ability to perform the verification of treatment plans, 
based upon the measured dwell positions and times. The introduction of the quantitative position-time 
gamma index allows for direct comparison of measured parameters against the plan, and could be 
used prior to patient treatment to ensure accurate delivery. 
1. Introduction 
Due to the severe consequences associated with the incorrect delivery of High Dose Rate (HDR) 
brachytherapy treatments, it is essential that the measurement of source dwell times and verification 
of dwell location can be undertaken with high precision. Human and calculation errors introduced 
during the treatment planning and preparation processes, in addition to incorrect calibration of the 
HDR afterloader, can potentially lead to incorrect dwell location and timing during treatment, 
resulting in the misadministration of dose to the treatment volume1,2,3. 
Brachytherapy treatment planning systems (TPS) employ algorithms based on the AAPM TG-43U1 
protocol4 to calculate dose distributions around the HDR source, and to plan the necessary treatment. 
Since the treatment relies on the correct delivery of the plan by the HDR remote afterloader, it is 
 
 
desirable to develop an independent quality assurance (QA) method that accurately verifies the HDR 
source dwell positioning and timing pattern for each catheter. A sound QA program should include a 
pre-treatment plan verification5 and would give confidence of a correct execution at the time of 
treatment. Although the afterloader has high precision in its control of the source movement, 
treatment outcomes of plans with multiple catheters are more susceptible to deviations in dwell 
position and time6.  
There have been efforts found within the literature to develop a method for verification of planned 
dwelling and timing patterns before and during treatment. These include pinhole imaging7,8, diamond 
detectors9, flat panel10 and EPIDs11, film and photodiodes12, ion chamber arrays13 and video cameras*. 
These devices, while capable of source tracking, can be costly and are limited in their ability to 
perform a quick, comprehensive and automated analysis of a full treatment plan.  
The feasibility study of a two dimensional detector array “magic plate”, housed inside a “magic 
phantom” (MPh), showed the “magic plate” to be capable of determining the source position within 
three dimensions with a fast acquisition speed (0.1 – 100 ms)14. This work seeks to evaluate the proof 
of concept performance of the novel MPh, with updated electronics and software toolkit, as a 
complete system for HDR pre-treatment plan and afterloader verification. We aim to show that the 
MPh has the potential to accurately measure the dwell positions and times of any treatment, compare 
those measured values against the treatment plan, determine any errors in delivery, and estimate the 
total dose delivered - including the transit dose contribution along the “magic plate” plane. 
The MPh system was CT scanned and using ONCENTRA® TPS (Nucletron, the Netherlands), two 
20 catheter treatment plans were created. The treatment plans were measured using the MPh and the 
dwell positioning and timing were evaluated based on a new acceptance criterion for HDR QA, 
named the position-time gamma index. Dose distributions were calculated by the developed software, 
                                                     
* Mick Radio-Nuclear Instruments, Inc., Mount Vernon, NY, USA, accessed: 11th of August 2014 (available 
URL: http://www.micknuclear.com/home/products/quality_assurance_tools.html) 
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All 121 MPh detectors were read out by an in-house designed front-end electronics system, named 
“AFE data acquisition system” (AFE DAQ)21,22. The system uses two Texas Instrument commercial 
electrometer AFE-0064 chips and is controlled by a CMRP designed FPGA master board. The timing 
of the system is accurately governed by a 20 MHz master clock on the FPGA board and has an 
estimated error in timing of 50 ns. This communicates to the PC via USB2.0, and is controlled by an 
in-house designed firmware. The AFE DAQ is capable of a variable integration time (between 14 to 
9900 μs), with a stable sampling frequency of 0.1 to 10 kHz, and allows for triggering from external 
sources for linear accelerator measurements or using an internal trigger signal. For this work, a 1 kHz 
sampling frequency and 100 μs integration time was used for all measurements.  
A custom software interface was developed in C++ to: a) communicate with the FPGA and drive the 
AFE DAQ; b) perform source tracking in real time and in post-processing; c) perform dwell position 
and timing analysis; and d) calculate the absorbed dose from the TG-43U1 protocol based on 
measured source dwelling position and time and compare it to the dose prescribed by the treatment 
plan. The system and software measures the charge generated in all 121 MPh detectors within the 
integration time, at a periodic sampling frequency. The response at each measurement frame for each 
detector was collected in a data file for post-processing.  
The software performs TG-43U14 dose calculations to predict the dose generated to the MPh plane, 
based upon the measured dwell position analysis, the HDR 192Ir Flexisource specifications23 and 
known source activity. This was compared to the dose predicted by the TPS for selected points, and 
dose maps were generated and verified experimentally using Gafchromic EBT3 film. Due to the 
manufacturers stated dose range of “1 cGy to > 40 Gy”†, the tested dose range of up to 90 Gy24 and 
relatively weak energy dependence for energies as low as 50 keV25,26, the use of Gafchromic EBT3 
appears well suited for use in 192Ir HDR dosimetry and plan verification.  
                                                     
† Ashland International Specialty Products (ISP) Advanced Materials, New Jersey, USA, Gafchromic EBT3 
product brochure (2011). 
 
 
The MPh was imaged using the CT scanner, and the images imported into the Nucletron 
ONCENTRA® TPS. Each small MPh detector element could be seen on the 3D image reconstruction, 
with each detector selected as a point for dose calculations. The source was programmed to dwell at 
various positions and times inside each of the 20 catheters to create a nonspecific treatment plan with 
a maximum dose of 600 cGy to a single detector element. Each catheter had varying dwell positions 
and times arranged in the plan in an unsystematic fashion. 
A copy of the plan was created and modified by a member of the hospital medical physics staff, 
without the supervision of the authors, and an undisclosed number of changes were made. The plan 
was altered by the inclusion of new dwell points, points shifted or removed, and dwell times 
lengthened or shortened, to simulate a scenario where there is a misadministration by the afterloader. 
Each plan was exported as a DICOM file, preserving the source dwell and timing information for each 
catheter and the calculated absorbed dose at each detector position on the MP. Both DICOM plan files 
were subsequently read by the custom software suite; first to compare the measured dwelling 
position-time pattern with the original plan and identify the modifications using the position-time 
gamma analysis, and then to verify that all alterations measured were indeed made within the 
modified plan. All plans were delivered using the Flexitron HDR afterloader (Nucletron, the 
Netherlands) at the St George Cancer Care Centre, Sydney. 
3. Methods 
3.A. Determination of source dwell positions and dwell times 
A method for determining the HDR 192Ir source position using a two dimensional detector array was 
introduced within the “magic plate” feasibility study14. It is based on the sampled dose rate 
measurements from the nine neighboring diodes with the largest signals, followed by an iterative 
optimization procedure that takes into account the angular response of the diodes27. This method 
calculates, for each frame of measurement, the x-y-z coordinates of the HDR source when in the FOV 
of the MPh detectors. Building upon these results, the software interface was designed to 
automatically determine the source dwell positions and dwell times from the treatment measurement. 
 
 
Time gaps between the last position of each catheter and the first dwell of the next catheter do not 
affect the source position determination, as there is extremely little signal when the source is outside 
of the phantom. When the maximum signal during a measurement frame is below a predetermined 
threshold level, the software does not execute the source position calculation algorithm. The threshold 
level is dependent on the expected range of source activity and corresponds to the estimated current 
generated within a detector by a source at a distance of 150 mm away in the z direction, inside the 
FOV of the MPh. The noise level is very low in this developed system, and consequently, has 
minimal bearing on measurements.  
The unmodified 20 catheter plan delivery was measured using the MPh and the source position was 
analyzed in post-processing. For each catheter, a position-frequency histogram was generated from 
the source tracking data. The sampled source position was binned and peaks appeared in the 
histogram when many measurements occurred at the same position, i.e. when the source was 
dwelling. The number of counts under each peak of the histogram corresponds to the measured dwell 
time, as the time for each count was dependent on the sampling frequency of the system. The dwell 
position and uncertainty was determined by the center and full width half maximum (FWHM) of the 
peak. These results were compared to the dwell position and times found within the treatment 
planning file. 
The position of the source is related to the tip of each catheter, which is registered in the frame of the 
MPh with coordinate system origin based on a left corner detector. A position calibration test, relative 
to the MPh origin, was performed by driving the source at multiple positions within a single catheter 
and simultaneously measuring with the MPh and exposing EBT3. The EBT3 film was registered to 
the MPh by fixing it rigidly between the “magic plate” and top catheter plane. The center of mass of 
each source image on the film and the dwell positions calculated by the software were compared with 
the planned dwell position. The planned dwell positions were based on the CT scan of the MPh with 
tip markers inside each catheter. 
3.B. Determination of the minimum measurable step size and dwell time 
 
 
The Flexitron HDR afterloader can be programmed to drive the HDR source using varying step sizes 
and dwell times, with a minimum of 1 mm and 0.1 s, respectively. To be feasible for plan verification, 
the MPh system must be able to determine dwell positions and times accurately, over this range of 
step sizes and dwell times.  
To assess the dwell position resolution of the system, the afterloader was programmed to deliver the 
HDR source through a single catheter, moving with progressively reduced step sizes down to 1 mm. 
Each dwell position had a programmed dwell time of 3 s and was measured using the MPh system. 
The transit time of the source from one dwell position to the next was also measured.  
To assess the dwell time resolution of the system, the HDR afterloader was programmed to drive the 
source to 3 dwell positions within a single catheter for the same amount of time. The measurement 
was repeated for a range of dwell times from 10 s down to 0.1 s.  
3.C. Position-time gamma index 
To quantitatively compare the source position and dwell times within the catheter to the treatment 
plan, a new metric is introduced based upon the dose-position gamma index. The use of the 2D 
gamma index in QA was first described by Low et al15 and was used to quantitatively compare dose 
distributions for external beam radiation therapy. It compares the dose difference, point-by-point, and 
the distance-to-agreement between the evaluated dose distribution and that of the reference dose 
distribution, and is used for analysis in sections 3.E and 4.E.  
Adopting the formalization of this method and applying it to HDR brachytherapy, it is possible to 
compare the measured treatment to the plan by evaluating the source dwell and timing patterns. By 
using acceptable distance-to-agreement and time-to-agreement criteria values, a pass-fail grade (pass 
if gamma value is equal to or less than 1) is determined for all measured dwell positions and times.  
Table 1 - Definition of symbols used for HDR position-time gamma index. 
Symbol Equation Description 
,  N/A The i-th dwell position,	 , and dwell 
 
 
time, , of set A within catheter n. 
,  N/A The j-th dwell position,	 , and dwell 
time, , of set B within catheter n. 
∆  N/A Distance-to-agreement criterion (DTA). 
∆  N/A Time-to-agreement criterion (TTA). 
,  ,   is the spatial difference between the 
i-th dwell position of set A and the j-th 
dwell position of set B for catheter n. 
,  ,   is the difference between the i-th 
dwell time of set A and the j-th dwell 
time of set B for catheter n 
,  
,
,
∆
,
∆
 
Generalized  index computed for all 
dwell positions and times of set A and 
set B for catheter n. 
 , ∀ ,  The  index - the minimum generalized 
 for the set B, ,  dwell 
positions and dwell times within catheter 
n. 
The formalization of this method is found in Table 1. Two sets, A and B, represent the measured and 
TPS dwell position timing patterns within catheter n. The gamma index compares the dwell positions 
within set B against those in set A. The gamma index was calculated twice; first to compare the 
treatment measured by the MPh (set B) against the treatment plan (set A), and then to compare the 
treatment plan (set B) against the measured (set A). This increases the robustness of the method, 
taking into account cases when sets A and B have unequal numbers of dwell positions due to positions 
introduced or missed by the afterloader. A graphical representation of the position-time criteria is seen 
in Figure 3. 
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disassembled and the top layer with catheter trenches was placed within a 30x30x30 cm2 Solid Water 
stack. A single piece of film was placed at the center of the stack, and a single catheter was inserted 
into a trench directly over the film, at an approximate source-to-film distance of 16 mm. 
ONCENTRA® TPS was used to calculate the necessary time to deliver a dose to the center of the 
film, with the 5 pieces of film irradiated to 100, 200, 400, 600 and 1000 cGy using a single dwell 
position. 
All pieces of film were pre-scanned and post-irradiation scanned using a 48-bit RGB transmission 
film scanner, the EPSON 10000XL, at a resolution of 300 dpi, with no color or sharpness corrections 
and at a consistent orientation and position to the scanner. Approximately 72 hours passed between 
film irradiation and scanning to ensure the film response had stabilized. The calibration films were 
scanned and the image files were measured using IMAGEJ (version 1.47v). Six consecutive scans 
were performed for each piece of film to ensure consistent performance of the scanner on the last 
three used for analysis. A calibration curve was generated for the red color channel based upon the 
largest change in optical density and exposed dose. The total uncertainty was calculated to be 
approximately 6.1% (1 S.D), based upon an uncertainty budget which considers the source-to-film 
position, scanner inhomogeneity and reproducibility and the TPS dose calculations and source activity 
measurements. 
Using the software, dose maps were generated along the MPh detector plane for the original treatment 
plan, the measured treatment based upon the measured dwell positions and times, and for the modified 
treatment plan. The original treatment plan was then measured by replacing the “magic plate” detector 
with EBT3 film. The film was cut to match the size of the “magic plate” and markings were made for 
alignment. Both the film and “magic plate” were later scanned using the scanner, so that the film dose 
map positions could be registered to those calculated by the MPh software. The change in optical 
density was converted to dose using the calibration curve. The dose maps were then compared using 
the 2D gamma analysis, with varying dose difference and distance-to-agreements criteria. Each map 
had a size of 10x10 cm2, with pixel dimensions of 0.5x0.5 mm2. 
 
 
The total transit dose for the MPh diode positions was also estimated by performing dose calculations 
for each measured source position between dwell positions, assuming a discrete source movement 
between consecutive frames.  
4. Results 
4.A. Determination of source dwell positions and dwell times 
Figure 4 shows the calculated source position and dwell time in a position within the first catheter 
verses time, determined by the algorithm described in detail in previous study14. It can be seen that the 
source travels from the afterloader and dwells at the furthest dwell position away from the catheter tip, 
and moves progressively closer. The TPS plan for this catheter is graphed for comparison and shows 
good agreement for positions larger than 5 mm from the coordinate origin based on the MPh corner 
detector. While the TPS does not take into account the motion of the source in transit between dwell 
points, it is possible to measure this due to the high speed of the MPh readout system.  
The last two dwell positions were close to the catheter tip and the edge of the FOV of the “magic 
plate”, and used fewer detectors for calculation of source position. As the source tracking algorithm is 
based upon the agreement of the detector with the largest response and its neighbors, reduced 
numbers of detectors can result in a shift in true position. For accurate source dwell position 
calculations, the TPS plan should be configured to set the last dwell points at least 5-10 mm away 
from the edge of the MPh FOV. While there is a reduction in useable catheter length for this particular 
design of “magic plate”, it will be possible to measure the dwell position accurately within a range of 
80-90 mm. This issue was considered for the design of the next generation of the “magic plate”, MP-
512, which features a larger area, 512 diodes and a 5 mm pitch between detectors.  
 
 
 
Figure 4 - Source tracking measurement and TPS plan for 
Catheter 1. The position calculated was relative to the MPh 
coordinate system. 
 
Figure 5 - Measured dwell position frequency histogram for 
Catheter 1. The net area of each peak corresponds to the 
total dwell time at the position. Each count represents 1 ms 
due to measurement frequency.  
A position frequency histogram was generated from the source tracking calculations for each catheter. 
Each histogram had a bin width of 0.1 mm and the counts of source position were related to the 
electronic sampling frequency. Each count within the histogram represented 1 ms of time that the 
source had spent at that calculated position. Figure 5 shows the histogram for Catheter 1. Each dwell 
point was seen to be a narrow peak, where the center was equal to the dwell position and the FWHM 
was the uncertainty of position. The number of counts converted to time under each peak is equal to 
the total dwell time for that dwell position.  
The calculated and TPS planned dwell position-time patterns for catheter 1 are also presented in 
Figure 6. Uncertainties in the dwell positions were typically of the order of 0.2 mm (2 S.D) and are 
unable to be seen on this graph. Good agreement between these dwell patterns were seen for the 
majority of points, except for those close to 0 mm, due to the edge of FOV effect. The dwell positions 
and times were compared to the treatment plan. 
 
 
 
Figure 6 – Dwell position frequency histogram and 
comparison of dwell position timing pattern for Catheter 1 
with the TPS plan. The circles show the total dwell time 
calculated from the corresponding peak at that position. 
 
Figure 7 - Difference between the measured and planned 
dwell positions for the MPh calculation and EBT3 film for 
single catheter measurement.  
Figure 7 shows the difference along the catheter length between the measured and planned dwell 
positions for the position calibration test. The source was driven through a single catheter towards the 
catheter tip and the EBT3 film was irradiated, while the MPh measured. Six dwell positions were 
identified by both the software and the film analysis with all differences less than 0.8 mm. An 
uncertainty of ± 0.25 mm (2 S.D) was estimated due to the coordinate registration of the film to the 
MPh reference frame. 
 
Figure 8 - Histogram showing the difference in dwell times 
of the Measured and TPS. 
 
Figure 9 - Difference between measured and planned dwell 
times against interdwell distance. 
The average difference between the measured dwell position and the TPS plan for 86 dwell positions 
was 0 ± 0.63 mm (2 S.D), taking into account the larger differences due to the edge of FOV effect. 
 
 
Seen in Figure 8, the dwell time differences were found to be less than 0.25 s, and the majority 
showed that the MPh measured less than the expected planned dwell times. It is expected that due to 
the highly accurate internal clock of the electronics used, the error in timing is extremely small. 
This difference in dwell time is most likely due to a feature of the Flexitron afterloader that reduces 
dwell times to compensate for additional dose delivered while the source is in transit between 
successive dwell points. In Figure 9, the differences in dwell times are plotted against the interdwell 
distances (the distance between two dwell positions), showing that the difference in dwell time for the 
subsequent position is proportional to the distance the source had to travel. An interdwell distance of 0 
mm represents the first dwell position within the catheter, where it is expected that there will be no 
change in dwell time.  
According to the ONCENTRA® MasterPlan Physics and Algorithms manual‡, it is assumed that this 
afterloader drives the source at a speed of 50 cm/s and for an interdwell distance of 50 mm the dwell 
time is reduced by a maximum of 0.1 s. It is noted that this feature may not be seen in some 
afterloaders. The measured dwell time differences are larger than expected but, as seen in the 
feasibility study for the “magic plate” detector, the average source speed was measured and found to 
vary from 12.5 to 37.5 cm/s based on interdwell distance14. Although a different afterloader was used 
for the feasibility study, if it is assumed they share similar average source speeds, the variation in 
dwell time difference can be justified.  
4.B. Determination of the minimum measurable interdwell distance and dwell time 
The HDR source was driven to 9 dwell positions in a single catheter, with spaces between dwell 
positions varying from 30 mm to 1 mm. As seen in Table 2, the dwell positions were determined by 
the MPh, and the system was capable of resolving the dwell positions separated by 1 mm. There is 
some deviation noted between dwell positions, which may be due to the edge of FOV effect 
                                                     
‡ Oncentra MasterPlan v3.2, Physics and Algorithms Manual, 192.739ENG-02, Nucletron, the 
Netherlands. 
 
 
previously discussed. The dwell times for each position were found to follow the trend of reduced 
times, as a function of interdwell distance (Figure 9) and agreed with the determined transit times. 
Table 2 – Comparison of the planned position in an HDR catheter and the position and time measured using the MPh. 
Planned position (mm) Measured position (mm) Measured dwell time (s) 
(± 0.001 s) 
Measured transit time (s) 
(± 0.001 s) 
83.6 83.49 ± 0.14 3.015 - 
53.6 53.82 ± 0.12 2.792 0.219 
33.6 34.23 ± 0.14 2.849 0.172 
23.6 23.95 ± 0.18 2.919 0.109 
18.6 18.27 ± 0.16 2.946 0.066 
14.6 15.06 ± 0.16 2.987 0.040 
11.6 11.54 ± 0.16 2.976 0.054 
9.6 8.72 ± 0.18 2.989 0.041 
8.6 7.35 ± 0.16 2.991 0.027 
The minimum measurable dwell time for the MPh system was evaluated by using three dwell 
positions, at 13.6 mm, 18.6 and 28.6 mm from the catheter tip, and varying the planned times. Each 
position was set to have the same dwell time, but these varied when measured, except for Position 1 
which was the first the source was driven to. In Table 3, it can be observed that the minimum dwell 
time that was measured was 0.067 ± 0.001 s (2.SD). Following the trend of dwell time reduction, for 
the planned dwell times of 0.1 s, Position 2 was expected to have a time of 0.01-0.02 s, but could not 
be detected by the system due to not being distinguishable within the position frequency histogram. 
Table 3 - Determination of the minimum measurable dwell time 
Planned dwell time (s) Measured dwell time (s) (± 0.001 s) 
TPS Position 1 (28.6 mm) Position 2 (18.6 mm) Position 3 (13.6 mm) 
10 10.012 9.914 9.955 
5 5.015 4.908 4.951 
3 3.014 2.898 2.955 
 
 
2 2.014 1.911 1.951 
1 1.013 0.916 0.957 
0.5 0.512 0.414 0.458 
0.3 0.315 0.213 0.256 
0.2 0.212 0.109 0.155 
0.1 0.107 Unable to determine 0.067 
The verification of the accuracy of all dwell times set by the TPS is impossible, as the afterloader 
always modifies the actual dwelling time by taking the transit time into account. We have, however, 
demonstrated an obvious relationship between the absolute dwell time and interdwell distance, which 
is noticeable for all dwell times. This shows that the timing capabilities of this developed system 
surpass the programmable limitations of the afterloader system. 
4.C. Position-time gamma analysis 
The software suite determines the dwell position and times for all the catheters and compares them 
against the treatment plan using the position-time gamma analysis. By applying the equations 
described in Table 1 to the dwell pattern of Catheter 1, the gamma index values for each dwell 
position were calculated and are shown in Figure 10. Taking into account the differences between the 
measured dwell position and times from section 4.A, the DTA and TTA were set to 1.3 mm and 0.3 s, 
respectively. Uncertainties were calculated based on the standard deviation of the dwell position 
measurement and the DTA criteria. 
 
 
 
Figure 10 - Gamma analysis for Catheter 1 (DTA = 1.3 mm, 
TTA = 0.3 s). 
 
Figure 11 - Gamma analysis for all catheters (DTA = 1.3 
mm, TTA = 0.3 s). 
Applying the gamma index to all 20 catheters, it can be seen from Figure 11 that the majority of the 
treatment (95%) have gamma values of less than or equal to 1. There are 5 points with gamma values 
greater than 1, but they are considered to pass, due to their uncertainty.  
4.D. Position-time gamma index on modified plan 
The modified plan was measured using the MPh and using the results from the position-time gamma 
analysis, an estimated 11 changes were expected to have been made to the treatment plan. One change 
to Catheter 3, seen in Figure 12, was the addition of a dwell position. This position was seen to be at 
17.2 ± 0.1 mm (2 S.D) from the coordinate origin, with a dwell time of 14 s. 
 
 
 
Figure 12 - Comparison of dwell pattern for Catheter 3 
against the TPS plan. It can be seen that the MPh measures a 
dwell position at 17.0 mm introduced within the modified 
plan. 
 
Figure 13 - Gamma analysis for Catheter 3 for the modified 
plan (DTA = 1.3 mm, TTA = 0.3 s). The introduced dwell 
position has a gamma value of 12.0 ± 1.9. 
The addition of the new dwell position causes the gamma analysis of this catheter, seen in Figure 13, 
to fail the pass-fail criteria. A gamma value of 12.0 ± 1.9 (2 S.D) was calculated based on the 
agreement between the additional measured position and the nearest TPS planned dwell point 
(position = 24.3, time = 11.3). Comparing the position-time gamma index for the entire modified 
treatment to the original plan, Figure 14 indicates 11 modified dwell positions. Upon analyzing the 
modified treatment plan DICOM, these 11 alterations were verified to be the introduced changes.  
 
Figure 14 - Gamma analysis for all catheters for the modified plan (DTA = 1.3 mm, TTA = 0.3 s). Each gamma value larger 
than 1 represents a dwell position either removed or introduced into the plan. 
 
 
4.E. Comparisons between “magic phantom” calculated dose, TPS and EBT3 film dose 
measurements 
The TPS DICOM file of the original plan was read by the MPh software, and the coordinates and 
value of each dose calculation were acquired. The software subsequently recalculated the dose at the 
same points using its own implementation of the TG-43U1 protocol, using the same planned 
parameters. Good agreement was found between the MPh software estimated doses for the 121 
positions and the TPS, with values within ± 0.75% (2 S.D) suggesting that the dose calculation engine 
based on predetermined dwell positions and times is correct. 
Two-dimensional 10x10 cm2 dose maps along the MPh plane were generated using the TG-43U1 
calculation tool with 0.5x0.5 mm2 pixel size. These were produced for the planned and measured 
source dwell positions and times of the original plan, and for the measured modified plan. The 
calculated 2D dose map for the measured dwell positions and times of the original plan is shown in 
Figure 15. The film was irradiated using the unmodified plan and processed to create a map with the 
same dimensions and resolution as the others. 
 
Figure 15 – Dose to the MPh detector plane calculated using 
TG-43U1, based upon measured dwell positions and times, 
without transit dose contribution. 
 
Figure 16 – The calculated total transit dose contribution, 
delivered to the MPh detector plane for the unmodified 
treatment plan. 
The MPh system was also capable of estimating the contribution of the total transit dose for this plan 
by calculating the dose delivered for the sampled transit positions only. Seen in Figure 16, the total 
maximum transit dose was calculated to be 18 cGy for the measured plan. This represents an average 
 
 
of 4.8 ± 2.3% (2 S.D) increase in dose delivered when compared to the total dose delivered from the 
dwell positions only. This result is dependent on the source activity and for this particular plan the 
transit dose contribution could double when delivered directly after a source exchange, assuming the 
same transit times. 
All dose distributions were compared using the 2D gamma analysis for varying dose difference and 
distance-to-agreement criteria, and the results are shown in Table 4. The dose difference value was 
calculated based upon the maximum dose within the compared maps. It is evident that by using a dose 
difference of 4% and distance-to-agreement of 3 mm, a pass rate of over 95% could be achieved for 
both the MPh dose map without the transit dose and the film for the original plan. When considering 
the transit dose contribution, a pass rate of over 90% for all criteria examined was obtained. This 
suggests that the reduction of the dwell times is an appropriate method to compensate for the total 
transit dose when executing this plan. Using lower criteria values reduced the pass rate for film, most 
likely due to the registration of the film position to the MPh and the associated uncertainty in the film 
dose calculation. 
Table 4 – Comparison of calculated dose maps against the reference TPS planned dwell positions and times. 
 
Evaluated maps 
Gamma pass rate (%) for dose difference and distance-to-agreement criteria 
2% / 2 mm 3% / 3 mm 4% / 3 mm 
Measured by the MPh - 
original plan 
80.6 94.0 98.3 
Measured by the MPh - 
original plan with 
transit dose 
90.6 98.3 99.9 
EBT3 film – original 
plan 
58.7 82.2 95.8 
 
 
Measured by MPh - 
modified plan 
30.1 40.3 49.3 
The modified plan gave a pass rate of 49.3% for the dose difference of 4% and distance-to-agreement 
of 3 mm, which was anticipated due to the simulated errors in afterloader delivery. Performing the 
dose calculations and using the 2D gamma analysis to compare the dose profiles allowed for 
additional verification of the treatment delivery, which could also be used to verify the dose 
calculations of the treatment planning system. 
5. Conclusion 
The novel “magic phantom” system and software has demonstrated its ability to verify treatment 
plans for HDR brachytherapy in terms of dwell position and times. Gross errors in source position and 
timing above 1.3 mm and 0.3 s have been shown to be measurable using the new position-time 
gamma index. The addition of a TG-43U1 calculation to the software allows for dosimetric 
information to be determined based upon the measured treatment plan and was shown to be in 
agreement with the TPS calculated values and with experimental EBT3 film results. 
In future work, the “magic phantom” will be used to verify real patient plans and will translate 
measured dwell positions and time patterns to 3D dose calculations, including contributions of dose 
associated with source transition. The comparison of planned 3D doses by TPS and calculated values 
will complement the innovative position-time gamma analysis and provide comprehensive QA of the 
entire treatment delivery. 
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